KATHRYN POULOS: Open Payments
NPI 1083988323 · PLYMOUTH, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$484 in 28 payments from 9 companies in 2025. Trend: 2023 $835 · 2024 $419 · 2025 $484
Food & beverage: $484
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $178 |
| ABBVIE INC. | 4 | $101 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Paratek Pharmaceuticals, Inc. | 2 | $46 |
| Lilly USA, LLC | 2 | $36 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Amgen Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
Products named: CAPLYTA, VRAYLAR, XHANCE, MOUNJARO, FARXIGA, KEVEYIS, BREZTRI, OTEZLA.
Industry payments across MI — which companies pay providers there.
